FROM CONCEPT TO MARKET
Dead / Cancelled — Cancelled — Section 8 (as of 15 Sept 2017)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78573983
- Registration number
- 3207404
- Mark type
- Stylized text
- Filed
- 24 Feb 2005
- Published for opposition
- 28 Nov 2006
- Registered
- 13 Feb 2007
- Attorney of record
- Joshua G. Gigger
Goods and services
- Class 035 — Advertising and business services: Identification of regulatory strategies for product market applications and reimbursement; preparation and submission of product applications to the FDA and other regulatory agencies; preparing business reports for governmental agencies and medical journals resulting from clinical studies; providing reimbursement and health economic services, namely, researching and analyzing current reimbursement policies, product and procedure codes and pricing; providing due diligence services, namely, evaluating regulatory strategies, clinical strategies, product reimbursement strategies and quality systems on behalf of venture capitalists
- Class 042 — Scientific and technological services: Contract regulatory and clinical services, namely, strategy development in the nature of consulting services regarding scientific and technical aspects of clinical trials and submissions to the FDA and other regulatory agencies; designing, implementing and managing clinical trials for product testing and development purposes; developing and managing clinical studies, clinical protocol, data management and analysis for clinical trials; preparing scientific reports resulting from clinical studies; developing and managing regulatory quality systems and compliance matters for medical product manufacturers; designing and implementing pre-clinical research services, namely, scientific animal research; preparing scientific reports as to results of studies for governmental agencies and medical journals resulting from clinical studies; designing animal medical experiments; designing, implementing and analyzing human clinical studies, namely, protocol development, site initiation, database development and management and data analysis
Owner
- Regulatory & Clinical Research Institute, Inc., Minneapolis, MN, US
- Regulatory & Clinical Research Institute, Inc., Minneapolis, MN, US
- Regulatory & Clinical Research Institute, Inc., Minneapolis, MN, US
Prosecution history
- 15 Sept 2017 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 13 Feb 2016 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 10 Feb 2016 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Feb 2016 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Mar 2012 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 21 Mar 2012 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 21 Mar 2012 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Feb 2012 — TEAS SECTION 8 & 15 RECEIVED
- 13 Feb 2007 — REGISTERED-PRINCIPAL REGISTER
- 28 Nov 2006 — PUBLISHED FOR OPPOSITION
- 08 Nov 2006 — NOTICE OF PUBLICATION
- 06 Oct 2006 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 29 Sept 2006 — ASSIGNED TO LIE
- 27 Sept 2006 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Sept 2006 — TEAS/EMAIL CORRESPONDENCE ENTERED